Page last updated: 2024-12-07

u 73343

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

U 73343: an inactive analog of U 73122 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID114825
CHEMBL ID1628215
SCHEMBL ID2678917
MeSH IDM0201927

Synonyms (24)

Synonym
u-73343
142878-12-4
1-[6-[[(8r,9s,13s,14s,17s)-3-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]amino]hexyl]pyrrolidine-2,5-dione
u73343
u 73343
unii-s2c4j8704c
2,5-pyrrolidinedione, 1-(6-(((17beta)-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-
1-(6-((17beta-3-methoxyestra-1,3,5(10)-triene-17-yl)amino)hexyl)-2,5-pyrrolidinedione
s2c4j8704c ,
SCHEMBL2678917
CHEMBL1628215
1-[6-[[(17?)-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-2,5-pyrrolidinedione
2,5-pyrrolidinedione, 1-(6-(((17.beta.)-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-
1-(6-(((17.beta.)-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-2,5-pyrrolidinedione
1-(6-((17beta-3-methoxyestra-1,3,5(10)-trien-17-yl)-amino)hexyl-2,5-pyrrolidine-dione
AKOS024457993
DTXSID2036740
1-(6-(((17beta)-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-2,5-pyrrolidinedione
Q27894098
u-73343 - cas 142878-12-4
1-(6-(((8r,9s,13s,14s,17s)-3-methoxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6h-cyclopenta[a]phenanthren-17-yl)amino)hexyl)pyrrolidine-2,5-dione
BCP12871
u-73343;u 73343
D87162

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In experiment 3, explants were incubated in the presence of oxytocin or arginine vasopressin at 10(-9) to 10(-6) M to establish dose-response curves for the activation of PLC and release of PGF2 alpha."( Cellular mechanisms mediating the stimulation of ovine endometrial secretion of prostaglandin F2 alpha in response to oxytocin: role of phospholipase C and diacylglycerol.
Brockman, JA; Hayes, SH; Lee, JS; Lowberger, LL; Silvia, WJ; Trammell, DS, 1994
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (97)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's35 (36.08)18.2507
2000's56 (57.73)29.6817
2010's5 (5.15)24.3611
2020's1 (1.03)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.33 (24.57)
Research Supply Index4.58 (2.92)
Research Growth Index4.33 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other97 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]